Skip to main content
Premium Trial:

Request an Annual Quote

Affy to Distribute Asuragen's IVT Reagent Kits for Molecular Diagnostics

NEW YORK (GenomeWeb News) - Affymetrix will market Asuragen’s in vitro transcription reagent kits for use with its diagnostic microarray platform, the companies said today.  
 
Under the terms of the agreement, Asuragen will develop and manufacture IVT reagent kits configured for use with Affy’s GeneChip System 3000Dx, a diagnostic microarray platform that has gained 510(k) clearance from the US Food and Drug Administration and the CE mark from the European Union.
 
Kevin King, president of Affymetrix, said in a statement that the kit will “strengthen our growing diagnostic product portfolio."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.